Shin, S.-U.; Cho, H.-M.; Das, R.; Gil-Henn, H.; Ramakrishnan, S.; Al Bayati, A.; Carroll, S.F.; Zhang, Y.; Sankar, A.P.; Elledge, C.;
et al. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. Cells 2021, 10, 2904.
https://doi.org/10.3390/cells10112904
AMA Style
Shin S-U, Cho H-M, Das R, Gil-Henn H, Ramakrishnan S, Al Bayati A, Carroll SF, Zhang Y, Sankar AP, Elledge C,
et al. Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. Cells. 2021; 10(11):2904.
https://doi.org/10.3390/cells10112904
Chicago/Turabian Style
Shin, Seung-Uon, Hyun-Mi Cho, Rathin Das, Hava Gil-Henn, Sundaram Ramakrishnan, Ahmed Al Bayati, Stephen F. Carroll, Yu Zhang, Ankita P. Sankar, Christian Elledge,
and et al. 2021. "Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases" Cells 10, no. 11: 2904.
https://doi.org/10.3390/cells10112904
APA Style
Shin, S.-U., Cho, H.-M., Das, R., Gil-Henn, H., Ramakrishnan, S., Al Bayati, A., Carroll, S. F., Zhang, Y., Sankar, A. P., Elledge, C., Pimentel, A., Blonska, M., & Rosenblatt, J. D.
(2021). Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases. Cells, 10(11), 2904.
https://doi.org/10.3390/cells10112904
